• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清脂联素,一种与系统性硬化症皮肤厚度相关的新型生物标志物。

Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis.

作者信息

Leodori Giorgia, Pellicano Chiara, Basile Valerio, Colalillo Amalia, Navarini Luca, Gigante Antonietta, Gulli Francesca, Marino Mariapaola, Basile Umberto, Rosato Edoardo

机构信息

Department of Translational and Precision Medicine, Sapienza University of Rome, 00189 Rome, Italy.

Clinical Pathology Unit and Cancer Biobank, Department of Research and Advanced Technologies, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.

出版信息

J Pers Med. 2022 Oct 19;12(10):1737. doi: 10.3390/jpm12101737.

DOI:10.3390/jpm12101737
PMID:36294874
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9604668/
Abstract

The aim was to evaluate the longitudinal association between basal serum adiponectin and repeated measurements of skin thickness during 12 months of follow-up in systemic sclerosis (SSc) patients. We enrolled SSc patients with disease duration > 2 years in a prospective observational study. Skin thickness was measured at baseline and after 12 months of follow-up with modified Rodnan skin score (mRSS). Baseline serum adiponectin was determined using a commercial ELISA kit. We enrolled 66 female SSc patients (median age 54 years, IQR 42−62 years). The median disease duration was 12 (IQR 8−16) years and median baseline serum adiponectin was 9.8 (IQR 5.6−15.6) mcg/mL. The median mRSS was 10 (IQR 6−18) at baseline and 12 (IQR 7−18) at follow-up. A significant correlation was observed between baseline serum adiponectin and disease duration (r = 0.264, p < 0.05), age (r = 0.515, p < 0.0001), baseline mRSS (r = −0.303, p < 0.05), and mRSS at follow-up (r = −0.322, p < 0.001). In multiple regression analysis, only mRSS at follow-up showed an inverse correlation with baseline serum adiponectin (β = −0.132, p < 0.01). The reduction in serum adiponectin levels is correlated with skin thickness.

摘要

目的是评估系统性硬化症(SSc)患者在12个月随访期间基础血清脂联素与重复测量皮肤厚度之间的纵向关联。我们纳入病程超过2年的SSc患者进行一项前瞻性观察性研究。在基线和随访12个月后,使用改良Rodnan皮肤评分(mRSS)测量皮肤厚度。使用商用ELISA试剂盒测定基线血清脂联素。我们纳入了66名女性SSc患者(中位年龄54岁,四分位间距42 - 62岁)。中位病程为12(四分位间距8 - 16)年,中位基线血清脂联素为9.8(四分位间距5.6 - 15.6)mcg/mL。基线时mRSS中位数为10(四分位间距6 - 18),随访时为12(四分位间距7 - 18)。观察到基线血清脂联素与病程(r = 0.264,p < 0.05)、年龄(r = 0.515,p < 0.0001)、基线mRSS(r = -0.303,p < 0.05)和随访时mRSS(r = -0.322,p < 0.001)之间存在显著相关性。在多元回归分析中,仅随访时的mRSS与基线血清脂联素呈负相关(β = -0.132,p < 0.01)。血清脂联素水平的降低与皮肤厚度相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae71/9604668/4cc37ef8502a/jpm-12-01737-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae71/9604668/8ac45d8becbd/jpm-12-01737-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae71/9604668/4cc37ef8502a/jpm-12-01737-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae71/9604668/8ac45d8becbd/jpm-12-01737-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae71/9604668/4cc37ef8502a/jpm-12-01737-g002.jpg

相似文献

1
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis.血清脂联素,一种与系统性硬化症皮肤厚度相关的新型生物标志物。
J Pers Med. 2022 Oct 19;12(10):1737. doi: 10.3390/jpm12101737.
2
Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study.皮肤厚度评分作为系统性硬化症器官受累的替代标志物:一项回顾性观察研究。
Arthritis Res Ther. 2019 May 28;21(1):129. doi: 10.1186/s13075-019-1919-6.
3
High burden of skin sclerosis is associated with severe organ involvement in patients with systemic sclerosis and systemic sclerosis overlap syndrome.皮肤硬化症负担高与系统性硬化症和重叠综合征患者严重的器官受累有关。
Rheumatol Int. 2018 Dec;38(12):2279-2288. doi: 10.1007/s00296-018-4156-4. Epub 2018 Sep 11.
4
Circulating Collagen Metabolites and the Enhanced Liver Fibrosis (ELF) Score as Fibrosis Markers in Systemic Sclerosis.循环胶原蛋白代谢产物及增强肝纤维化(ELF)评分作为系统性硬化症的纤维化标志物
Front Pharmacol. 2022 Feb 1;13:805708. doi: 10.3389/fphar.2022.805708. eCollection 2022.
5
Long-term Outcomes After Rituximab Treatment for Patients With Systemic Sclerosis: Follow-up of the DESIRES Trial With a Focus on Serum Immunoglobulin Levels.利妥昔单抗治疗系统性硬化症患者的长期结局:DESIRES 试验的随访结果,重点关注血清免疫球蛋白水平。
JAMA Dermatol. 2023 Apr 1;159(4):374-383. doi: 10.1001/jamadermatol.2022.6340.
6
Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis.皮肤增厚的早期轨迹与系统性硬化症的严重程度和死亡率相关。
Arthritis Res Ther. 2020 Feb 18;22(1):30. doi: 10.1186/s13075-020-2113-6.
7
Skin fibrosis correlates with circulating thyrotropin levels in systemic sclerosis: translational association with Hashimoto's thyroiditis.皮肤纤维化与系统性硬化症患者的促甲状腺激素循环水平相关:与桥本甲状腺炎的转化关联。
Endocrine. 2016 Feb;51(2):291-7. doi: 10.1007/s12020-015-0600-3. Epub 2015 May 21.
8
Adiponectin relation to skin changes and dyslipidemia in systemic sclerosis.脂联素与系统性硬化症皮肤改变和血脂异常的关系。
Cytokine. 2012 May;58(2):165-8. doi: 10.1016/j.cyto.2012.02.003. Epub 2012 Feb 27.
9
High frequency ultrasound of skin involvement in systemic sclerosis - a follow-up study.系统性硬化症皮肤受累的高频超声——一项随访研究
Arthritis Res Ther. 2015 Nov 19;17:329. doi: 10.1186/s13075-015-0853-5.
10
High-frequency ultrasound of the skin in systemic sclerosis: an exploratory study to examine correlation with disease activity and to define the minimally detectable difference.系统性硬皮病皮肤高频超声:一项探索性研究,旨在检查与疾病活动的相关性,并定义最小可检测差异。
Arthritis Res Ther. 2018 Aug 16;20(1):181. doi: 10.1186/s13075-018-1686-9.

引用本文的文献

1
Circulating adiponectin levels in systemic sclerosis: A meta-analysis and bidirectional Mendelian randomization study.系统性硬化症中循环脂联素水平:一项荟萃分析和双向孟德尔随机化研究
J Scleroderma Relat Disord. 2025 Jul 17:23971983251352341. doi: 10.1177/23971983251352341.
2
Biomarkers reflecting the pathogenesis, clinical manifestations, and guide therapeutic approach in systemic sclerosis: a narrative review.反映系统性硬化症发病机制、临床表现和指导治疗方法的生物标志物:叙述性综述。
Clin Rheumatol. 2024 Oct;43(10):3055-3072. doi: 10.1007/s10067-024-07123-y. Epub 2024 Aug 29.

本文引用的文献

1
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫苗接种对系统性硬化症患者B细胞表型的影响
J Pers Med. 2022 Aug 31;12(9):1420. doi: 10.3390/jpm12091420.
2
Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis.皮肤和肺部纤维化的系统性硬化症患者补体激活增加。
J Pers Med. 2022 Feb 15;12(2):284. doi: 10.3390/jpm12020284.
3
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity.
系统性硬化症患者血清和尿液游离轻链检测:疾病活动的新型生物标志物。
Clin Exp Immunol. 2021 Aug;205(2):135-141. doi: 10.1111/cei.13611. Epub 2021 Jun 2.
4
An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis.一种口服活性脂联素受体激动剂可减轻系统性硬化症小鼠模型的皮肤纤维化、炎症和微血管病变。
Sci Rep. 2018 Aug 7;8(1):11843. doi: 10.1038/s41598-018-29901-w.
5
Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target.脂联素是一种内源性抗纤维化介质和治疗靶点。
Sci Rep. 2017 Jun 30;7(1):4397. doi: 10.1038/s41598-017-04162-1.
6
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis.用于系统性硬化症临床试验的改良罗德南皮肤评分的标准化。
J Scleroderma Relat Disord. 2017 Jan-Apr;2(1):11-18. doi: 10.5301/jsrd.5000231.
7
Serum adipokines levels in patients with systemic sclerosis: A meta-analysis.系统性硬化症患者血清脂肪因子水平:一项荟萃分析。
Mod Rheumatol. 2017 Mar;27(2):298-305. doi: 10.1080/14397595.2016.1193106. Epub 2016 Jun 20.
8
Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors.脂肪细胞衍生素阳性真皮内祖细胞可分化为小鼠皮肤纤维化中的肌成纤维细胞。
Arthritis Rheumatol. 2015 Apr;67(4):1062-73. doi: 10.1002/art.38990.
9
Editorial: Fate of fat tissue adipocytes: do they transform into myofibroblasts in scleroderma?社论:脂肪组织脂肪细胞的命运:它们在硬皮病中会转化为肌成纤维细胞吗?
Arthritis Rheumatol. 2015 Apr;67(4):860-1. doi: 10.1002/art.38988.
10
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database.使用 EUSTAR 数据库预测弥漫性皮肤系统性硬皮病患者皮肤纤维化的恶化。
Ann Rheum Dis. 2015 Jun;74(6):1124-31. doi: 10.1136/annrheumdis-2014-205226. Epub 2014 Jun 30.